JANUET 50/850 MG TABLETS

Χώρα: Ισραήλ

Γλώσσα: Αγγλικά

Πηγή: Ministry of Health

Δραστική ουσία:

METFORMIN HYDROCHLORIDE 850 MG; SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG

Διαθέσιμο από:

MERCK SHARP & DOHME ISRAEL LTD

Φαρμακολογική κατηγορία (ATC):

A10BA02

Φαρμακοτεχνική μορφή:

TABLETS

Οδός χορήγησης:

PER OS

Κατασκευάζεται από:

MERCK SHARP & DOHME CORP., USA

Θεραπευτική ομάδα:

METFORMIN

Θεραπευτικές ενδείξεις:

Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use:Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet.

Ημερομηνία της άδειας:

2008-12-01